A novel treatment that uses a disintegrating matrix for sustained release of medication led to improvement in vision and reduced supplemental treatment in patients with diabetic macular edema, ...

The Ghana FDA’s approval was granted following a rigorous, science-based regulatory review that referenced comprehensive data ...

Ocular Therapeutix (OCUL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

ANI Pharmaceuticals jumps 7% as 2026 guidance tops expectations, with strong sales and EPS growth fueled by momentum in the ...

Detailed price information for Abpro Holdings Inc (ABP-Q) from The Globe and Mail including charting and trades.

These preliminary results are based on management's initial analysis of operations for the quarter and year ended January 3, 2026, and are subject to the completion of the Company’s year-end financial ...

Celltrion’s senior executives attended the conference to present the company’s latest progress in new drug development and long-term growth strategy. The presentation took place on Tuesday, January 13 ...

Oculis Holding AG (OCS) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 4:30 PM ESTCompany ParticipantsRiad Sherif - CEO ...

Detailed price information for Oculis Holding Ag (OCS-Q) from The Globe and Mail including charting and trades.

What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” ...

Guangzhou Runer Ophthalmic Biotechnology Co. Ltd. has divulged compounds acting as complement factor B (CFB) inhibitors reported to be useful for the treatment of age-related macular degeneration, ...